Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

Ziihera, a therapeutic antibody developed using ProBioGen's proprietary GlymaxX technology, has become commercially available ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

Both companies will work to revolutionize cell culture media in biotech and the vaccine industry with animal-free, high-yield ...

Bristol Myers Squibb’s Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with ...

Precision Medicine Group, a provider of next-generation drug development, CRO and commercialization services, has appointed Eric Hodgins as its Chief Information and Technology Officer, overseeing all ...

Thermo Fisher Scientific Inc. has introduced the 5L DynaDrive Single-Use Bioreactor, expanding the company's portfolio of ...

Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has appointed Thomas ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Lonza will serve as a CMAC Translation to Industry Collaborator, reinforcing its commitment to advancing innovative ...

Intas Pharmaceuticals has completed its acquisition of the UDENYCA (pegfilgrastim-cbqv) business from Coherus BioSciences Inc ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...